These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37335827)

  • 1. Addressing Cardiovascular Risk in Diabetes: It's More Than the Sugar.
    Ozkan B; Ndumele CE
    Circulation; 2023 Jun; 147(25):1887-1890. PubMed ID: 37335827
    [No Abstract]   [Full Text] [Related]  

  • 2. Widespread diabetes screening for cardiovascular disease risk estimation.
    Arnett DK
    Lancet; 2021 Jun; 397(10291):2228-2230. PubMed ID: 34089657
    [No Abstract]   [Full Text] [Related]  

  • 3. Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population.
    Cebrián-Cuenca AM; Mata-Cases M; Franch-Nadal J; Mauricio D; Orozco-Beltrán D; Consuegra-Sánchez L
    Eur J Prev Cardiol; 2022 Feb; 28(18):e32-e34. PubMed ID: 33733654
    [No Abstract]   [Full Text] [Related]  

  • 4. Obesity, Diabetes, and Cardiovascular Diseases: A Compendium.
    Scherer PE; Hill JA
    Circ Res; 2016 May; 118(11):1703-5. PubMed ID: 27230636
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac Computed Tomography for Personalized Management of Patients With Type 2 Diabetes Mellitus.
    Cardoso R; Dudum R; Ferraro RA; Bittencourt M; Blankstein R; Blaha MJ; Nasir K; Rajagopalan S; Michos ED; Blumenthal RS; Cainzos-Achirica M
    Circ Cardiovasc Imaging; 2020 Sep; 13(9):e011365. PubMed ID: 32900225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing cardiovascular risk in type 2 diabetes: Let's use all we have!
    Bonaventura A
    Int J Cardiol; 2020 Jul; 310():155-156. PubMed ID: 32331901
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diabetes mellitus, coronary artery disease and heart disease (Update 2023)].
    Clodi M; Saely CH; Hoppichler F; Resl M; Steinwender C; Stingl H; Wascher TC; Winhofer Y; Sourij H
    Wien Klin Wochenschr; 2023 Jan; 135(Suppl 1):201-206. PubMed ID: 37101042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes Mellitus and Its Cardiovascular Complications: New Insights into an Old Disease.
    Sardu C; De Lucia C; Wallner M; Santulli G
    J Diabetes Res; 2019; 2019():1905194. PubMed ID: 31236416
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes.
    Thomas M; Magwire M; Gosch K; Sammour Y; Mehta R; O'Keefe J; Nassif ME; Kosiborod M
    Circ Cardiovasc Qual Outcomes; 2021 Oct; 14(10):e007682. PubMed ID: 34587753
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: Precursors of Cardiovascular Disease in Adolescent Type 1 Diabetes.
    Hoffman RP
    Curr Diabetes Rev; 2017; 13(6):519. PubMed ID: 29039272
    [No Abstract]   [Full Text] [Related]  

  • 11. Lifestyle behaviors and cardiovascular risk profiles among parous women by gestational diabetes status, 2007-2018.
    Dorans KS; Bazzano LA; Li X; Bundy JD; Tian L; He J
    Nutr Metab Cardiovasc Dis; 2022 May; 32(5):1121-1130. PubMed ID: 35210134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal audit of assessment and pharmaceutical intervention for cardiovascular risk in the Australasian Diabetes Data Network.
    Robertson CA; Earnest A; Chee M; Craig ME; Colman P; Barrett HL; Bergman P; Cameron F; Davis EA; Donaghue KC; Fegan PG; Hamblin PS; Holmes-Walker DJ; Jefferies C; Johnson S; Mok MT; King BR; Sinnott R; Ward G; Wheeler BJ; Zimmermann A; Jones TW; Couper JJ;
    Diabetes Obes Metab; 2022 Feb; 24(2):354-361. PubMed ID: 34713959
    [No Abstract]   [Full Text] [Related]  

  • 13. Performance of a protein biomarker panel for prediction of cardiovascular events in patients with diabetes mellitus.
    Mohebi R; McCarthy CP; Magaret CA; Barnes G; Rhyne RF; Peters C; Gaggin HK; Januzzi JL
    Eur J Prev Cardiol; 2022 May; 29(8):e270-e271. PubMed ID: 35258630
    [No Abstract]   [Full Text] [Related]  

  • 14. Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    Arnott C; Li Q; Kang A; Neuen BL; Bompoint S; Lam CSP; Rodgers A; Mahaffey KW; Cannon CP; Perkovic V; Jardine MJ; Neal B
    J Am Heart Assoc; 2020 Feb; 9(3):e014908. PubMed ID: 31992158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex.
    Matsubayashi Y; Fujihara K; Yamada-Harada M; Mitsuma Y; Sato T; Yaguchi Y; Osawa T; Yamamoto M; Kitazawa M; Yamada T; Kodama S; Sone H
    Cardiovasc Diabetol; 2022 Jun; 21(1):90. PubMed ID: 35655263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetes mellitus, coronary artery disease und heart disease (Update 2019)].
    Clodi M; Saely CH; Hoppichler F; Resl M; Steinwender C; Stingl H; Wascher TC; Winhofer-Stöckl Y; Sourij H
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):169-173. PubMed ID: 30980152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus.
    Nargesi AA; Jeyashanmugaraja GP; Desai N; Lipska K; Krumholz H; Khera R
    J Am Heart Assoc; 2021 Jul; 10(13):e021084. PubMed ID: 33998258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide cardiovascular risk categorization: applying the European Society of Cardiology guidelines to the Swedish National Diabetes Register.
    Eliasson B; Ekelund J; Holmberg CN; Wolden ML; Matthiessen KS; James S
    Eur J Prev Cardiol; 2023 May; 30(7):546-551. PubMed ID: 36567502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of childhood glucose homeostasis variables in predicting adult diabetes and related cardiometabolic risk factors: the Bogalusa Heart Study: comment on Nguyen et Al.
    d'Annunzio G; Russo C; Lorini R
    Diabetes Care; 2010 Sep; 33(9):e123; author reply e124. PubMed ID: 20805265
    [No Abstract]   [Full Text] [Related]  

  • 20. Type 2 diabetes mellitus in heterozygous familial hypercholesterolaemia: the hazardous intersection of cardiometabolic and genetic risk.
    German CA; Shapiro MD
    Eur J Prev Cardiol; 2022 Jan; 28(16):1817-1818. PubMed ID: 33961017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.